AU6642996A - Biomarkers and targets for diagnosis, prognosis and management of prostate disease - Google Patents
Biomarkers and targets for diagnosis, prognosis and management of prostate diseaseInfo
- Publication number
- AU6642996A AU6642996A AU66429/96A AU6642996A AU6642996A AU 6642996 A AU6642996 A AU 6642996A AU 66429/96 A AU66429/96 A AU 66429/96A AU 6642996 A AU6642996 A AU 6642996A AU 6642996 A AU6642996 A AU 6642996A
- Authority
- AU
- Australia
- Prior art keywords
- biomarkers
- prognosis
- targets
- diagnosis
- management
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1996/012516 WO1998004689A1 (en) | 1995-07-31 | 1996-07-31 | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
Publications (2)
Publication Number | Publication Date |
---|---|
AU6642996A true AU6642996A (en) | 1998-02-20 |
AU712403B2 AU712403B2 (en) | 1999-11-04 |
Family
ID=22255530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU66429/96A Ceased AU712403B2 (en) | 1996-07-31 | 1996-07-31 | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
Country Status (3)
Country | Link |
---|---|
AT (1) | ATE311450T1 (en) |
AU (1) | AU712403B2 (en) |
DE (1) | DE69635526T2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114113633A (en) * | 2021-12-27 | 2022-03-01 | 复旦大学 | Molecular index and kit for prostate cancer risk degree diagnosis and curative effect evaluation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5262311A (en) * | 1992-03-11 | 1993-11-16 | Dana-Farber Cancer Institute, Inc. | Methods to clone polyA mRNA |
US5639656A (en) * | 1994-03-31 | 1997-06-17 | Medical College Of Hampton Road | Antibodies reactive with biological markers of benign prostate hyperplasia |
US5633161A (en) * | 1995-03-29 | 1997-05-27 | Millennium Pharmaceuticals, Inc. | Murine gene fomy030 coding for tumor progression inhibitor |
-
1996
- 1996-07-31 AU AU66429/96A patent/AU712403B2/en not_active Ceased
- 1996-07-31 AT AT96926195T patent/ATE311450T1/en not_active IP Right Cessation
- 1996-07-31 DE DE69635526T patent/DE69635526T2/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114113633A (en) * | 2021-12-27 | 2022-03-01 | 复旦大学 | Molecular index and kit for prostate cancer risk degree diagnosis and curative effect evaluation |
CN114113633B (en) * | 2021-12-27 | 2024-05-24 | 复旦大学 | Molecular index and kit for diagnosing risk and evaluating curative effect of prostate cancer |
Also Published As
Publication number | Publication date |
---|---|
DE69635526T2 (en) | 2006-08-17 |
AU712403B2 (en) | 1999-11-04 |
ATE311450T1 (en) | 2005-12-15 |
DE69635526D1 (en) | 2006-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4560499A (en) | Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer | |
AU5212199A (en) | Methods and kits for diagnosing and determination of the predisposition of diseases | |
EP1090291A4 (en) | Method for early diagnosis of, and determination of prognosis in, cancer | |
AU3897999A (en) | Multi-analyte diagnostic system and computer implemented process for same | |
AU6409799A (en) | Tissue analysis and kits therefor | |
AU1724000A (en) | Diagnostic assay for cancer | |
AU2922497A (en) | Detection probes, kits and assays | |
AU6688598A (en) | Method for diagnosing and staging prostate cancer | |
AU2149700A (en) | Systems for the analysis of gene expression data | |
AU1748597A (en) | Disk caching disk | |
AU1465801A (en) | Methods for cancer prognosis and diagnosis | |
AU1662100A (en) | System and method for the optimization of data collection | |
AU5291098A (en) | Pipe lining method | |
AU1810899A (en) | Neuropilins and use thereof in methods for diagnosis and prognosis of cancer | |
AU2735797A (en) | Detection probes, kits and assays | |
AU3944497A (en) | 1,2-diarylindole as cox-2 inhibitors | |
AU6425800A (en) | Agents for the diagnosis, prognosis and treatment of malignant diseases | |
AU2218199A (en) | Method for identifying validated target and assay combinations | |
AU1930099A (en) | Tokenless financial access system | |
AU3364899A (en) | Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer | |
AU4150999A (en) | Method and kit for early diagnosis of cancer | |
AU2714500A (en) | Method and system for target register allocation | |
AU6642996A (en) | Biomarkers and targets for diagnosis, prognosis and management of prostate disease | |
AU6214199A (en) | Pipe liner and pipe lining method | |
AU3239895A (en) | Method of using hyaluronic acid for the detection, location and diagnosis of tumors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |